RYHTY (Ryman Healthcare) Piotroski F-Score: 5 (As of Jun. 24, 2026) — Near Median


RYHTY Ryman Healthcare Ltd RYHTY
70 GF Score
Price $6.11
GF Value $17.68
! 2 Warning Signs
View Full Analysis

What is Ryman Healthcare Piotroski F-Score?

Ryman Healthcare RYHTY -12.82% 70 Piotroski F-Score is 5 as of Jun. 24, 2026, which is at its 10-year median of 5.00. GuruFocus rates RYHTY with a GF Score™ of 70/100 and a GF Value™ of $17.68. The stock has 2 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Ryman Healthcare ranks better than 54.38% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ryman Healthcare has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Ryman Healthcare's Piotroski F-Score or its related term are showing as below:

RYHTY' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 6
Current: 5

During the past 13 years, the highest Piotroski F-Score of Ryman Healthcare was 6. The lowest was 2. And the median was 5.

Ryman Healthcare  (OTCPK:RYHTY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Ryman Healthcare Piotroski F-Score Related Terms


Ryman Healthcare Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Ryman Healthcare's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ryman Healthcare Piotroski F-Score Chart

Ryman Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 5.00 6.00 5.00 5.00

Ryman Healthcare Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 0.00 5.00 0.00 5.00

RYHTY vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Ryman Healthcare's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryman Healthcare Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Ryman Healthcare's Piotroski F-Score falls into.


RYHTY
70GF Score
Ryman Healthcare Ltd RYHTY
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Net Income was $-250.2 Mil.
Cash Flow from Operations was $235.0 Mil.
Revenue was $408.8 Mil.
Gross Profit was $408.8 Mil.
Average Total Assets from the begining of this year (Mar24)
to the end of this year (Mar25) was (7958.687 + 6909.142) / 2 = $7433.9145 Mil.
Total Assets at the begining of this year (Mar24) was $7,958.7 Mil.
Long-Term Debt & Capital Lease Obligation was $970.9 Mil.
Total Current Assets was $123.7 Mil.
Total Current Liabilities was $509.6 Mil.
Net Income was $2.9 Mil.

Revenue was $395.7 Mil.
Gross Profit was $395.7 Mil.
Average Total Assets from the begining of last year (Mar23)
to the end of last year (Mar24) was (7765.75 + 7958.687) / 2 = $7862.2185 Mil.
Total Assets at the begining of last year (Mar23) was $7,765.8 Mil.
Long-Term Debt & Capital Lease Obligation was $1,562.7 Mil.
Total Current Assets was $495.3 Mil.
Total Current Liabilities was $227.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ryman Healthcare's current Net Income (TTM) was -250.2. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Ryman Healthcare's current Cash Flow from Operations (TTM) was 235.0. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar24)
=-250.19/7958.687
=-0.03143609

ROA (Last Year)=Net Income/Total Assets (Mar23)
=2.905/7765.75
=0.00037408

Ryman Healthcare's return on assets of this year was -0.03143609. Ryman Healthcare's return on assets of last year was 0.00037408. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Ryman Healthcare's current Net Income (TTM) was -250.2. Ryman Healthcare's current Cash Flow from Operations (TTM) was 235.0. ==> 235.0 > -250.2 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=970.942/7433.9145
=0.13060979

Gearing (Last Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=1562.691/7862.2185
=0.19875955

Ryman Healthcare's gearing of this year was 0.13060979. Ryman Healthcare's gearing of last year was 0.19875955. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar25)=Total Current Assets/Total Current Liabilities
=123.725/509.632
=0.24277322

Current Ratio (Last Year: Mar24)=Total Current Assets/Total Current Liabilities
=495.302/227.162
=2.18039109

Ryman Healthcare's current ratio of this year was 0.24277322. Ryman Healthcare's current ratio of last year was 2.18039109. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Ryman Healthcare's number of shares in issue this year was 142.038. Ryman Healthcare's number of shares in issue last year was 146.088. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=408.818/408.818
=1

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=395.702/395.702
=1

Ryman Healthcare's gross margin of this year was 1. Ryman Healthcare's gross margin of last year was 1. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar24)
=408.818/7958.687
=0.05136752

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar23)
=395.702/7765.75
=0.05095477

Ryman Healthcare's asset turnover of this year was 0.05136752. Ryman Healthcare's asset turnover of last year was 0.05095477. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+1+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Ryman Healthcare has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Ryman Healthcare (RYHTY) has a Piotroski F-Score of 5 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ryman Healthcare and its competitors. This is near median its historical median of 5.00. Over the past decade, Ryman Healthcare's Piotroski F-Score has ranged from 2.00 to 6.00. According to the industry distribution chart, Ryman Healthcare ranks #297 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 45.6%.
Is Ryman Healthcare's Piotroski F-Score too high?
Ryman Healthcare's current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 6.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Ryman Healthcare's value of 5 is 0% at this industry median. Based on the distribution chart, Ryman Healthcare ranks #297 out of 651 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ryman Healthcare has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ryman Healthcare ranks #297 out of 651 companies for Piotroski F-Score. This puts Ryman Healthcare in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Ryman Healthcare's value of 5 is 0% at this benchmark. Historically, Ryman Healthcare's own Piotroski F-Score has ranged from 2.00 to 6.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Ryman Healthcare has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ryman Healthcare's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Ryman Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ryman Healthcare's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (RYHTY) has a current Piotroski F-Score of 5. The stock's GF Value™ is $17.68, compared to a current price of $6.11 — trading 65.4% below its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Ryman Healthcare's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Ryman Healthcare (RYHTY), the current Piotroski F-Score is 5 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ryman Healthcare (RYHTY) Overvalued in 2026?

Based on GuruFocus' analysis, Ryman Healthcare stock appears to be undervalued. The current stock price of $6.11 is trading 65.4% below its estimated GF Value™ of $17.68.

Key valuation signals for RYHTY:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: $17.68 vs. price of $6.11 (65.4% below fair value)
  • GF Score™: 70/100 with 2 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#297 of 651)

No single metric tells the full story. See the RYHTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ryman Healthcare Business Description

Address 92 Russley Road, P.O. Box 771, Christchurch, CT, NZL, 8042
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
70GF Score

Get the complete analysis for RYHTY

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.11
Price
$17.68
GF Value